Immunotherapies can accomplish much, but we can only unlock their true power through collaboration.

Experts share their insights on the disruptive trends reshaping healthcare, including the rise of personalized medicine and digital innovation.

A curated collection of articles examining critical questions and advancements in vaccine science and policy.

A look back at The Medicine Maker archive and the influence of science fiction in the industry and science.

So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?

Alcami experts discuss what’s needed to accelerate drug development.

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.

A partnership between WhiteLab Genomics and Debiopharm will seek to use AI to streamline the development of targeted cancer therapies.

Why a forward-thinking approach is crucial for patient safety and industry success